UNITED THERAPEUTICS CORP
UTHRNASDAQ🏆 #570 by market capEarnings Oct 27 · PreUS Equity
$481.52▼ $4.29 (−0.89%)
After hours · at closeTrack UTHR
Get earnings, price moves & breaking news on Telegram
24h▼ 0.9%
7d▼ 3.2%
14d▼ 3.8%
30d▼ 6.6%
ytd▼ 1.1%
1y▲ 13.4%
🏦Market Cap
$20.44B
Mid Cap
📈Revenue Growth (YoY)
+10.6%
Healthy
📊Gross Margin
86.1%
High
💵FCF Margin
34.6%
Strong
⚖️P/S Ratio
6.4x
Fair
Otter Score
68
Fair
UNITED THERAPEUTICS CORP
UTHRAnalyst Ratings
Price
$481.52
Total
30
Raised
5
Lowered
3
Avg PT
$567.75
H / L
$735 / $321
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-08-06 | $587.00 | +21.90% |
JP Morgan | Reiterated | Overweight | 2026-07-23 | $238.00 | −50.60% |
B of A Securities | Reiterated | Neutral | 2026-07-10 | — | — |
Wells Fargo | Upgraded | Equal Weight → Overweight | 2026-05-07 | $735.00 | +52.60% |
Morgan Stanley | Reiterated | Equal Weight | 2026-04-10 | $515.00 | +7.00% |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-31 | — | — |
TD Cowen | Reiterated | Buy | 2026-03-30 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-03-12 | $625.00 | +29.80% |
UBS | Reiterated | Buy | 2026-03-05 | $645.00 | +34.00% |
Oppenheimer | Reiterated | Outperform | 2026-02-26 | $575.00 | +19.40% |
Jefferies | Reiterated | Buy | 2025-09-02 | $575.00 | +19.40% |
Goldman Sachs | Reiterated | Neutral | 2024-11-01 | $321.00 | −33.30% |
Ladenburg Thalmann | Reiterated | Buy | 2024-10-31 | — | — |
Argus Research | Reiterated | Buy | 2024-10-31 | $400.00 | −16.90% |
Wedbush | Reiterated | Outperform | 2024-02-22 | — | — |
Credit Suisse | Reiterated | Outperform | 2022-05-24 | $247.00 | −48.70% |
BTIG | Reiterated | Neutral | 2022-02-11 | — | — |
Cowen & Co. | Upgraded | Market Perform → Outperform | 2020-02-27 | — | — |
Barclays | Reiterated | Underweight | 2019-03-01 | — | — |
Standpoint Research | Upgraded | Hold → Buy | 2018-10-12 | — | — |
Argus | Upgraded | Hold → Buy | 2018-05-05 | — | — |
H.C. Wainwright | Downgraded | Buy → Neutral | 2016-06-15 | $600.00 | +24.60% |
Leerink Swann | Reiterated | Market Perform → Perform | 2015-04-29 | — | — |
BTIG Research | Reiterated | Neutral | 2015-01-06 | — | — |
Standpoint | Upgraded | Hold → Buy | 2014-10-15 | — | — |
BMO Capital | Reiterated | Market Perform | 2013-07-26 | — | — |
Deutsche Bank | Reiterated | Hold | 2013-02-27 | — | — |
Brean Capital | Downgraded | Buy → Hold | 2013-02-26 | — | — |
Guggenheim | Reiterated | Neutral | 2013-01-23 | — | — |
Canaccord Genuity | Downgraded | Buy → Hold | 2012-04-27 | — | — |
Institution
RBC Capital
Reiterated · Outperform · 2026-08-06
$587.00
+21.90%
JP Morgan
Reiterated · Overweight · 2026-07-23
$238.00
−50.60%
B of A Securities
Reiterated · Neutral · 2026-07-10
—
—
Wells Fargo
Upgraded · Equal Weight → Overweight · 2026-05-07
$735.00
+52.60%
Morgan Stanley
Reiterated · Equal Weight · 2026-04-10
$515.00
+7.00%
HC Wainwright & Co.
Reiterated · Buy · 2026-03-31
—
—
TD Cowen
Reiterated · Buy · 2026-03-30
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-03-12
$625.00
+29.80%
UBS
Reiterated · Buy · 2026-03-05
$645.00
+34.00%
Oppenheimer
Reiterated · Outperform · 2026-02-26
$575.00
+19.40%
Jefferies
Reiterated · Buy · 2025-09-02
$575.00
+19.40%
Goldman Sachs
Reiterated · Neutral · 2024-11-01
$321.00
−33.30%
Ladenburg Thalmann
Reiterated · Buy · 2024-10-31
—
—
Argus Research
Reiterated · Buy · 2024-10-31
$400.00
−16.90%
Wedbush
Reiterated · Outperform · 2024-02-22
—
—
Credit Suisse
Reiterated · Outperform · 2022-05-24
$247.00
−48.70%
BTIG
Reiterated · Neutral · 2022-02-11
—
—
Cowen & Co.
Upgraded · Market Perform → Outperform · 2020-02-27
—
—
Barclays
Reiterated · Underweight · 2019-03-01
—
—
Standpoint Research
Upgraded · Hold → Buy · 2018-10-12
—
—
Argus
Upgraded · Hold → Buy · 2018-05-05
—
—
H.C. Wainwright
Downgraded · Buy → Neutral · 2016-06-15
$600.00
+24.60%
Leerink Swann
Reiterated · Market Perform → Perform · 2015-04-29
—
—
BTIG Research
Reiterated · Neutral · 2015-01-06
—
—
Standpoint
Upgraded · Hold → Buy · 2014-10-15
—
—
BMO Capital
Reiterated · Market Perform · 2013-07-26
—
—
Deutsche Bank
Reiterated · Hold · 2013-02-27
—
—
Brean Capital
Downgraded · Buy → Hold · 2013-02-26
—
—
Guggenheim
Reiterated · Neutral · 2013-01-23
—
—
Canaccord Genuity
Downgraded · Buy → Hold · 2012-04-27
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space